Erschienen in:
01.11.2007 | Thoracic Oncology
Overexpression of Axin Downregulates TCF-4 and Inhibits the Development of Lung Cancer
verfasst von:
Hong-Tao Xu, MD, PhD, Qiang Wei, MD, PhD, Yang Liu, MD, PhD, Lian-He Yang, MD, Shun-Dong Dai, MD, PhD, Yang Han, MD, PhD, Juan-Han Yu, MD, Nan Liu, MD, En-Hua Wang, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 11/2007
Einloggen, um Zugang zu erhalten
Abstract
Background
T cell factor 4 (TCF-4) mediates a nuclear response to wingless/int (Wnt) signals by interacting with β-catenin. Axis inhibition protein (axin) is an important negative regulator of the Wnt signaling pathway. Our aims were to examine the relationship between axin and TCF-4 and to explore the effects of axin on the development of lung cancer.
Methods
Expression levels of axin and TCF-4 were examined in 107 lung cancer specimens by immunohistochemistry. The axin gene was transfected into lung cancer BE1 cells. The expression levels of axin, β-catenin, and TCF-4 were detected with immunofluorescence and reverse transcription-polymerase chain reaction (RT-PCR) experiments. Apoptosis, proliferation, and the invasive ability of lung cancer cells were examined using flow cytometry, 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT), and Matrigel invasive assays.
Results
Preserved axin expression correlated negatively with TCF-4 expression (P = .031). Axin expression differed with respect to degree of differentiation (P = .025) and histological tumor type (P = .031). TCF-4 expression differed relative to tumor, node metastasis (TNM) stage (P = .024). BE1 cells transfected with axin (BE1-axin cells) exhibited a significant decrease in TCF-4 expression. The level of apoptosis in BE1-axin cells was significantly increased, while the proliferative and invasive abilities of BE1-axin cells were decreased.
Conclusion
These results suggest that reduced expression of axin or augmented expression of TCF-4 is associated with the malignant behavior of lung cancers. Overexpression of axin can downregulate expression of TCF-4 and can inhibit the ability of lung cancer cells to proliferate and invade.